Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06510725
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-09
Brief Title:
Effect of Multitarget tDCS for Neuropathic Pain
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effect of Multitarget Transcranial Direct Current Stimulation tDCS in Patients With Neuropathic Pain
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to conduct a randomized controlled trial to evaluate the effect of multitarget transcranial direct current stimulation tDCS on pain depression anxiety quality of life and sleep in patients with neuropathic pain
Detailed Description:
The present multicenter randomized double-blind sham-controlled parallel-group trial aims to evaluate the effect of multitarget transcranial direct current stimulation tDCS in patients with neuropathic pain
The patients will be randomized to receive one of 3 treatment arms multitarget stimulation single-target stimulation and sham stimulation All patients received 20 minutes of active or sham tDCS once a day for 10 consecutive weekdays In multitarget group subjects will receive 2mA tDCS applied to M1 and DLPFC alternately with each target stimulated for 5 sessions In single-target group 2mA tDCS will target M1 only In sham group subjects will receive sham tDCS Ramps up and down will be applied for 15 seconds each at the beginning and end of the session The current will be 0 mA during the interval between the initial and final ramps
The patients will be randomized to receive one of 3 treatment arms multitarget stimulation single-target stimulation and sham stimulation All patients received 20 minutes of active or sham tDCS once a day for 10 consecutive weekdays In multitarget group subjects will receive 2mA tDCS applied to M1 and DLPFC alternately with each target stimulated for 5 sessions In single-target group 2mA tDCS will target M1 only In sham group subjects will receive sham tDCS Ramps up and down will be applied for 15 seconds each at the beginning and end of the session The current will be 0 mA during the interval between the initial and final ramps
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None